Financial News
All news about Sanofi-Aventis S.A.
Dow poised to skid 200 point amid setbacks on U.S. fiscal relief package and Brexit
December 11, 2020
From MarketWatch
A Look Into Sanofi's Debt
December 11, 2020
From Benzinga
There’s one reason big growth stocks have outperformed over the last decade — and that’s about to change, strategist says
December 11, 2020
From MarketWatch
A Peek Into The Markets: US Stock Futures Down; Pfizer Covid-19 Vaccine Gets FDA Panel's Nod
December 11, 2020
From Benzinga
European stocks stumble on COVID-19 vaccine setback, while U.S. equity futures fall on stimulus worries
December 11, 2020
From MarketWatch
GSK-Sanofi COVID-19 Vaccine Shows Insufficient Immunity, Late-Stage Trials Delayed
December 11, 2020
From Benzinga
Emerging Markets Hit Record High: 5 Top-Performing ETFs YTD
December 10, 2020
Tags
ETFs
From Blogs - TalkMarkets
Up Almost 2,000% in 2020, Is Vaxart Still a Buy?
December 10, 2020
From Motley Fool
3 Best Biotech Stocks of 2020: Are They Buys Now?
December 10, 2020
From Motley Fool
Moderna Analyst Positive On Coronavirus Vaccine Progress, Downgrades Shares On Valuation
December 09, 2020
From Benzinga
Canadians living with multiple sclerosis find support during COVID-19 pandemic through dedicated social media network
December 08, 2020
From PR Newswire
How You Can Profit From the Best-Managed Drugmaker on Earth
December 08, 2020
From Motley Fool
Anti-Fibrinolytic Drugs Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2021-2026 | ExpertMarketResearch.com
December 07, 2020
From iCrowdNewswire
These 3 Stocks Would Benefit If Governments Send More Stimulus Checks
December 06, 2020
From Motley Fool
3 Top Healthcare Stocks to Buy Right Now
December 06, 2020
From Motley Fool
The Flu Gives This Coronavirus Vaccine Stock A Surprising Edge
December 05, 2020
From Motley Fool
3 Coronavirus Vaccine Stocks That Still Have Strong Upside
December 05, 2020
From Motley Fool
These 30 companies have increased sales and boosted margins the most during the pandemic
December 04, 2020
From MarketWatch
Is Novavax Stock a Buy?
December 01, 2020
From Motley Fool
A Look Into Healthcare Sector Value Stocks
November 30, 2020
From Benzinga
Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
November 28, 2020
From Blogs - TalkMarkets
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
November 28, 2020
From Benzinga
EU strikes deal with Moderna to supply up to 160 million vaccine shots
November 24, 2020
The European Union has now negotiated six supply deals with vaccine makers to secure COVID-19 shots.
From MarketWatch
From Motley Fool
Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
November 22, 2020
From Blogs - TalkMarkets
The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
November 22, 2020
From Benzinga
Week In Review: How Trump's Policies Moved Stocks - Saturday, Nov. 21
November 21, 2020
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
